Published on
August 5, 2026
- 18:33 GMT
Medicare Establishes Dedicated Reimbursement for InVision's AI Detection of Cardiac Amyloidosis
CMS finalizes a New Technology Add-on Payment (NTAP) under code XEZZXLC, effective October 1, 2026, completing a Medicare payment pathway for InVision. PALO ALTO, CA, UNITED STATES, August 5, 2026 /EINPresswire.com/ -- InVision Medical Technology …
Distribution channels:
Healthcare & Pharmaceuticals Industry
...
